Caffeine is the most widely consumed psychoactive substance in the UK and one of the most under-discussed when prescribing or selling medicines. Most caffeine interactions are clinically minor, but a small number — clozapine, lithium, theophylline, iron and several common OTC analgesics — can produce real problems. Pharmacy teams who recognise the patterns can prevent unnecessary dose changes, avoidable side effects and the occasional emergency presentation.
This guide summarises the caffeine interactions most relevant to community pharmacy practice, drawing on the BNF, the MHRA Drug Safety Update bulletins and Stockley's Drug Interactions.
How caffeine behaves in the body
Caffeine is metabolised principally by the cytochrome P450 isoenzyme CYP1A2, with a smaller contribution from CYP2E1 and N-acetyltransferase. Half-life in adults is around 5 hours, prolonged in pregnancy (up to 10 hours), in liver disease, and with co-administration of CYP1A2 inhibitors. Smokers metabolise caffeine roughly 50% faster than non-smokers because cigarette smoke induces CYP1A2.
This means caffeine levels rise:
- After smoking cessation (a doubling of caffeine effect is common in the first weeks after quitting)
- With CYP1A2 inhibitors (ciprofloxacin, fluvoxamine, oral contraceptives)
- In pregnancy and lactation
- In liver impairment
Clinically important interactions
Clozapine
Clozapine is metabolised by CYP1A2. Caffeine is a competitive substrate. High caffeine intake increases clozapine plasma concentrations by 25–50%, which can precipitate sedation, hypotension, seizures or agranulocytosis-monitoring complications. Conversely, an abrupt change in caffeine intake can shift clozapine levels.
Counselling point: patients on clozapine should be advised to keep caffeine intake stable; any change should be reported to the mental health team. Smoking cessation is a particularly important trigger for review of clozapine levels.
Theophylline and aminophylline
Theophylline shares metabolic pathways with caffeine. Concomitant high caffeine intake increases the risk of theophylline toxicity (tachycardia, tremor, nausea, seizures). The BNF advises minimising caffeine in patients on theophylline; if a sudden change occurs (smoking cessation, illness, addition of ciprofloxacin), theophylline level monitoring should be requested.
Lithium
Caffeine increases renal clearance of lithium. A heavy daily caffeine drinker who suddenly cuts back may experience a 20–30% rise in lithium levels and a clinical lithium toxicity episode. The interaction works in both directions; counselling should focus on consistency rather than abstinence.
Iron
Tea, coffee and cocoa contain polyphenols (notably tannins) that bind non-haem iron and reduce absorption substantially — by up to 60–80% when consumed within an hour of an iron tablet. The standard advice is to take iron tablets with water and a vitamin C source (orange juice, fresh fruit) and to avoid tea or coffee within the hour before and after the dose.
Adenosine
Caffeine is a non-selective adenosine receptor antagonist. Adenosine, used in cardiac pharmacological stress tests, is rendered ineffective by recent caffeine intake. Patients are advised to avoid caffeine for 12–24 hours before the test; some centres extend to 48 hours.
Some antidepressants
Selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors interact with caffeine via shared CYP1A2 metabolism, although the clinical impact is usually limited. Fluvoxamine is a particularly potent CYP1A2 inhibitor, raising caffeine concentrations 5–10 fold; jitteriness, palpitations and insomnia in patients on fluvoxamine should prompt a caffeine intake review.
Beta-blockers
The hypertensive and tachycardic responses to caffeine are partly mediated by beta-adrenergic activity. Beta-blockers attenuate these effects. The interaction is rarely clinically significant but may matter where a patient self-medicates with caffeine for symptomatic effect (e.g. exercise, asthma).
Anti-arrhythmics
Caffeine can precipitate atrial and ventricular ectopics in susceptible patients. A trial of caffeine reduction is reasonable in patients reporting palpitations on amiodarone, flecainide, or with paroxysmal atrial fibrillation.
Caffeine in over-the-counter medicines
Many OTC analgesics include caffeine to enhance the perceived analgesic effect. The Cochrane review (Derry 2014) suggests a small but real benefit from caffeine doses ≥ 100 mg. Patients on caffeine-restricted regimens may inadvertently exceed limits.
| Product | Caffeine per dose | Adult daily max (per pack) |
|---|---|---|
| Anadin Extra (per 2 tablets) | ~90 mg | up to ~720 mg if at maximum dose |
| Solpadeine Plus / Max (per 2 tablets) | 60–65 mg | varies |
| Migraleve Pink | ~20 mg per tablet | dose-dependent |
| Panadol Extra (per 2 tablets) | ~130 mg | up to ~520 mg in 24 hours |
| Pro Plus (each tablet) | 50 mg | OTC stimulant |
A standard mug of brewed coffee contains roughly 80–120 mg of caffeine; a strong filter coffee can exceed 200 mg. The European Food Safety Authority single-dose advisory limit for healthy adults is 200 mg; the daily limit is 400 mg. Pregnant women are advised to limit intake to 200 mg per day. Patients combining caffeinated analgesics with their usual coffee can easily exceed both limits, particularly during a migraine or cold-and-flu episode.
Specific patient groups
Pregnancy. Caffeine intake above 200 mg/day has been associated with low birthweight in observational studies. Pregnant patients on iron supplementation should be told about the absorption interaction; those taking caffeinated analgesics should be told to count the OTC caffeine in the daily total.
Breastfeeding. Caffeine appears in breast milk at peak concentration about an hour after maternal intake. Modest intake (up to 200 mg) is generally compatible with breastfeeding; higher intake may produce irritability and poor sleep in the infant.
Children and adolescents. EFSA recommends a single-dose limit of 3 mg/kg. Energy drinks and high-strength coffees can easily exceed this. Caffeine-containing OTC analgesics are not recommended in under-12s.
Older adults. Slower hepatic metabolism, polypharmacy and cardiovascular comorbidity make caffeine effects more pronounced. Counselling should consider total daily intake including OTC analgesics, decaf-labelled drinks (which still contain ~5–15 mg per cup) and caffeinated soft drinks.
A counselling structure
A short, structured caffeine question fits within a 60-second consultation:
- How much caffeine each day from coffee, tea, cola, energy drinks?
- Are you taking any OTC pain relief or cold and flu products that contain caffeine?
- Have you recently stopped smoking?
- Are you on clozapine, lithium, theophylline, iron supplements, or a CYP1A2 inhibitor?
If any answer is positive, the conversation moves into specific advice — almost always about consistency rather than abstinence.
PharmSee's pharmacy directory helps patients find a community pharmacy for a face-to-face medicines review; the pharmacist career hub covers the role of the community pharmacist in safe self-care advice. The PharmSee jobs board lists pharmacist and pharmacy technician vacancies across the UK.
Sources
- BNF — Drug interactions appendix
- Stockley's Drug Interactions, current edition
- MHRA Drug Safety Update — clozapine and CYP1A2 considerations
- European Food Safety Authority — Scientific opinion on the safety of caffeine
- Cochrane Review — Caffeine as an analgesic adjuvant for acute pain in adults (Derry 2014)